| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | 147.0 | 559.0 | 20.0 | - | - | - | 726 |
| 1 | - | - | - | - | 3.0 | 35.0 | 2.0 | - | - | - | 40 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 121 |
| 1 | 50 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 165 |
| 1 | 164 |
| Number of post synapses: | 726 |
| Number of pre synapses: | 40 |
| Number of output connections: | 71 |
| Coverage factor: | 1.0 |
| Columnar completeness: | 0.23 |
| Area completeness: | 0.57 |
| Cell size (columns): | 201 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#MeVP63 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Cm11d (R) | ACh | 120 | 120.0 | 13.8% | 13.8% |
| 1 | Dm8b (R) | Glu | 82 | 82.0 | 9.4% | 23.2% |
| 2 | MeVP2 (R) | ACh | 57 | 57.0 | 6.6% | 29.8% |
| 3 | aMe1 (R) | GABA | 50 | 50.0 | 5.8% | 35.6% |
| 4 | Dm2 (R) | ACh | 45 | 45.0 | 5.2% | 40.7% |
| 5 | aMe17e (R) | Glu | 41 | 41.0 | 4.7% | 45.5% |
| 6 | Mi15 (R) | ACh | 41 | 41.0 | 4.7% | 50.2% |
| 7 | MeVC22 (R) | Glu | 27 | 27.0 | 3.1% | 53.3% |
| 8 | aMe17a (R) | Glu | 26 | 26.0 | 3.0% | 56.3% |
| 9 | MeVPaMe2 (L) | Glu | 26 | 26.0 | 3.0% | 59.3% |
| 10 | Tm29 (R) | Glu | 26 | 26.0 | 3.0% | 62.3% |
| 11 | aMe9 (R) | ACh | 22 | 22.0 | 2.5% | 64.8% |
| 12 | MeVPMe7 (L) | Glu | 20 | 20.0 | 2.3% | 67.1% |
| 13 | TmY10 (R) | ACh | 19 | 19.0 | 2.2% | 69.3% |
| 14 | R7_unclear (R) | His | 17 | 17.0 | 2.0% | 71.2% |
| 15 | aMe9 (L) | ACh | 15 | 15.0 | 1.7% | 73.0% |
| 16 | Cm11b (R) | ACh | 14 | 14.0 | 1.6% | 74.6% |
| 17 | Cm9 (R) | Glu | 13 | 13.0 | 1.5% | 76.1% |
| 18 | Cm3 (R) | GABA | 12 | 12.0 | 1.4% | 77.4% |
| 19 | MeTu3b (R) | ACh | 10 | 10.0 | 1.2% | 78.6% |
| 20 | Cm26 (R) | Glu | 9 | 9.0 | 1.0% | 79.6% |
| 21 | Cm2 (R) | ACh | 8 | 8.0 | 0.9% | 80.6% |
| 22 | aMe2 (R) | Glu | 7 | 7.0 | 0.8% | 81.4% |
| 23 | MeVC11 (L) | ACh | 7 | 7.0 | 0.8% | 82.2% |
| 24 | MeVP41 (R) | ACh | 7 | 7.0 | 0.8% | 83.0% |
| 25 | R7p (R) | His | 7 | 7.0 | 0.8% | 83.8% |
| 26 | MeLo4 (R) | ACh | 6 | 6.0 | 0.7% | 84.5% |
| 27 | Dm11 (R) | Glu | 5 | 5.0 | 0.6% | 85.0% |
| 28 | MeTu3c (R) | ACh | 5 | 5.0 | 0.6% | 85.6% |
| 29 | Tm5a (R) | ACh | 5 | 5.0 | 0.6% | 86.2% |
| 30 | aMe12 (R) | ACh | 4 | 4.0 | 0.5% | 86.7% |
| 31 | Cm11c (R) | ACh | 4 | 4.0 | 0.5% | 87.1% |
| 32 | MeVP21 (R) | ACh | 4 | 4.0 | 0.5% | 87.6% |
| 33 | Mi1 (R) | ACh | 4 | 4.0 | 0.5% | 88.0% |
| 34 | Pm12 (R) | Glu | 4 | 4.0 | 0.5% | 88.5% |
| 35 | Tm5c (R) | Glu | 4 | 4.0 | 0.5% | 89.0% |
| 36 | TmY17 (R) | ACh | 4 | 4.0 | 0.5% | 89.4% |
| 37 | Cm1 (R) | ACh | 3 | 3.0 | 0.3% | 89.8% |
| 38 | Cm10 (R) | GABA | 3 | 3.0 | 0.3% | 90.1% |
| 39 | Cm27 (R) | Glu | 3 | 3.0 | 0.3% | 90.4% |
| 40 | Tm40 (R) | ACh | 3 | 3.0 | 0.3% | 90.8% |
| 41 | TmY9b (R) | ACh | 3 | 3.0 | 0.3% | 91.1% |
| 42 | aMe17c (R) | Glu | 2 | 2.0 | 0.2% | 91.4% |
| 43 | aMe4 (R) | ACh | 2 | 2.0 | 0.2% | 91.6% |
| 44 | aMe5 (R) | ACh | 2 | 2.0 | 0.2% | 91.8% |
| 45 | Cm-DRA (R) | ACh | 2 | 2.0 | 0.2% | 92.1% |
| 46 | Cm11a (R) | ACh | 2 | 2.0 | 0.2% | 92.3% |
| 47 | Cm21 (R) | GABA | 2 | 2.0 | 0.2% | 92.5% |
| 48 | Cm25 (R) | Glu | 2 | 2.0 | 0.2% | 92.8% |
| 49 | Cm28 (R) | unclear | 2 | 2.0 | 0.2% | 93.0% |
| 50 | Cm31a (R) | GABA | 2 | 2.0 | 0.2% | 93.2% |
| 51 | Cm35 (R) | GABA | 2 | 2.0 | 0.2% | 93.4% |
| 52 | Cm4 (R) | Glu | 2 | 2.0 | 0.2% | 93.7% |
| 53 | DN1a (R) | unclear | 2 | 2.0 | 0.2% | 93.9% |
| 54 | Lat1 (R) | unclear | 2 | 2.0 | 0.2% | 94.1% |
| 55 | MeVC20 (R) | Glu | 2 | 2.0 | 0.2% | 94.4% |
| 56 | MeVCMe1 (R) | ACh | 2 | 2.0 | 0.2% | 94.6% |
| 57 | MeVP1 (R) | ACh | 2 | 2.0 | 0.2% | 94.8% |
| 58 | MeVP14 (R) | ACh | 2 | 2.0 | 0.2% | 95.1% |
| 59 | MeVPMe12 (L) | ACh | 2 | 2.0 | 0.2% | 95.3% |
| 60 | OA-AL2i4 (R) | OA | 2 | 2.0 | 0.2% | 95.5% |
| 61 | Tm5b (R) | ACh | 2 | 2.0 | 0.2% | 95.7% |
| 62 | TmY13 (R) | ACh | 2 | 2.0 | 0.2% | 96.0% |
| 63 | 5thsLNv_LNd6 (R) | ACh | 1 | 1.0 | 0.1% | 96.1% |
| 64 | aMe12 (L) | ACh | 1 | 1.0 | 0.1% | 96.2% |
| 65 | aMe26 (R) | ACh | 1 | 1.0 | 0.1% | 96.3% |
| 66 | aMe6b (R) | ACh | 1 | 1.0 | 0.1% | 96.4% |
| 67 | aMe6c (R) | Glu | 1 | 1.0 | 0.1% | 96.5% |
| 68 | CL125 (R) | unclear | 1 | 1.0 | 0.1% | 96.7% |
| 69 | Cm14 (R) | GABA | 1 | 1.0 | 0.1% | 96.8% |
| 70 | Cm17 (R) | GABA | 1 | 1.0 | 0.1% | 96.9% |
| 71 | Cm19 (R) | GABA | 1 | 1.0 | 0.1% | 97.0% |
| 72 | Cm23 (R) | Glu | 1 | 1.0 | 0.1% | 97.1% |
| 73 | Cm29 (R) | GABA | 1 | 1.0 | 0.1% | 97.2% |
| 74 | Cm5 (R) | GABA | 1 | 1.0 | 0.1% | 97.4% |
| 75 | Dm8a (R) | Glu | 1 | 1.0 | 0.1% | 97.5% |
| 76 | Dm9 (R) | Glu | 1 | 1.0 | 0.1% | 97.6% |
| 77 | DNpe053 (R) | ACh | 1 | 1.0 | 0.1% | 97.7% |
| 78 | l-LNv (R) | unclear | 1 | 1.0 | 0.1% | 97.8% |
| 79 | L1 (R) | Glu | 1 | 1.0 | 0.1% | 97.9% |
| 80 | Lat3 (R) | unclear | 1 | 1.0 | 0.1% | 98.0% |
| 81 | ME_unclear (R) | ACh | 1 | 1.0 | 0.1% | 98.2% |
| 82 | MeTu1 (R) | ACh | 1 | 1.0 | 0.1% | 98.3% |
| 83 | MeVC27 (L) | unclear | 1 | 1.0 | 0.1% | 98.4% |
| 84 | MeVC9 (L) | ACh | 1 | 1.0 | 0.1% | 98.5% |
| 85 | MeVP15 (R) | ACh | 1 | 1.0 | 0.1% | 98.6% |
| 86 | MeVP17 (R) | Glu | 1 | 1.0 | 0.1% | 98.7% |
| 87 | MeVP31 (R) | ACh | 1 | 1.0 | 0.1% | 98.8% |
| 88 | MeVP43 (R) | ACh | 1 | 1.0 | 0.1% | 99.0% |
| 89 | MeVP6 (R) | Glu | 1 | 1.0 | 0.1% | 99.1% |
| 90 | MeVP9 (R) | ACh | 1 | 1.0 | 0.1% | 99.2% |
| 91 | MeVPLo2 (R) | ACh | 1 | 1.0 | 0.1% | 99.3% |
| 92 | MeVPMe11 (L) | Glu | 1 | 1.0 | 0.1% | 99.4% |
| 93 | MeVPMe13 (R) | ACh | 1 | 1.0 | 0.1% | 99.5% |
| 94 | Mi19 (R) | 5HT | 1 | 1.0 | 0.1% | 99.7% |
| 95 | OA-AL2i3 (R) | OA | 1 | 1.0 | 0.1% | 99.8% |
| 96 | PLP211 (R) | unclear | 1 | 1.0 | 0.1% | 99.9% |
| 97 | Tm37 (R) | Glu | 1 | 1.0 | 0.1% | 100.0% |
| instance | NT | total connections | connections /#MeVP63 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | 5thsLNv_LNd6 (R) | ACh | 89 | 89.0 | 26.6% | 26.6% |
| 1 | DNp27 (R) | unclear | 51 | 51.0 | 15.2% | 41.8% |
| 2 | SLP249 (R) | unclear | 28 | 28.0 | 8.4% | 50.1% |
| 3 | aMe_TBD1 (R) | unclear | 17 | 17.0 | 5.1% | 55.2% |
| 4 | Tm36 (R) | ACh | 16 | 16.0 | 4.8% | 60.0% |
| 5 | Cm26 (R) | Glu | 15 | 15.0 | 4.5% | 64.5% |
| 6 | LNd_b (R) | unclear | 14 | 14.0 | 4.2% | 68.7% |
| 7 | MeVC20 (R) | Glu | 13 | 13.0 | 3.9% | 72.5% |
| 8 | MeVP2 (R) | ACh | 12 | 12.0 | 3.6% | 76.1% |
| 9 | MeVP14 (R) | ACh | 9 | 9.0 | 2.7% | 78.8% |
| 10 | SMP217 (R) | unclear | 9 | 9.0 | 2.7% | 81.5% |
| 11 | aMe8 (R) | ACh | 6 | 6.0 | 1.8% | 83.3% |
| 12 | Cm31a (R) | GABA | 5 | 5.0 | 1.5% | 84.8% |
| 13 | SLP250 (R) | unclear | 5 | 5.0 | 1.5% | 86.3% |
| 14 | aMe20 (R) | unclear | 3 | 3.0 | 0.9% | 87.2% |
| 15 | LoVP96 (R) | Glu | 3 | 3.0 | 0.9% | 88.1% |
| 16 | aMe17e (R) | Glu | 2 | 2.0 | 0.6% | 88.7% |
| 17 | Cm1 (R) | ACh | 2 | 2.0 | 0.6% | 89.3% |
| 18 | l-LNv (R) | unclear | 2 | 2.0 | 0.6% | 89.9% |
| 19 | SMP229 (R) | unclear | 2 | 2.0 | 0.6% | 90.4% |
| 20 | Tm37 (R) | Glu | 2 | 2.0 | 0.6% | 91.0% |
| 21 | Tm5c (R) | Glu | 2 | 2.0 | 0.6% | 91.6% |
| 22 | aMe13 (R) | unclear | 1 | 1.0 | 0.3% | 91.9% |
| 23 | aMe17c (R) | Glu | 1 | 1.0 | 0.3% | 92.2% |
| 24 | aMe22 (R) | Glu | 1 | 1.0 | 0.3% | 92.5% |
| 25 | aMe4 (R) | ACh | 1 | 1.0 | 0.3% | 92.8% |
| 26 | aMe6c (R) | Glu | 1 | 1.0 | 0.3% | 93.1% |
| 27 | Cm11a (R) | ACh | 1 | 1.0 | 0.3% | 93.4% |
| 28 | Cm30 (R) | GABA | 1 | 1.0 | 0.3% | 93.7% |
| 29 | Cm32 (R) | GABA | 1 | 1.0 | 0.3% | 94.0% |
| 30 | Cm8 (R) | GABA | 1 | 1.0 | 0.3% | 94.3% |
| 31 | Dm8a (R) | Glu | 1 | 1.0 | 0.3% | 94.6% |
| 32 | LoVC23 (L) | GABA | 1 | 1.0 | 0.3% | 94.9% |
| 33 | LT58 (R) | Glu | 1 | 1.0 | 0.3% | 95.2% |
| 34 | MeVC21 (R) | Glu | 1 | 1.0 | 0.3% | 95.5% |
| 35 | MeVC23 (R) | Glu | 1 | 1.0 | 0.3% | 95.8% |
| 36 | MeVP1 (R) | ACh | 1 | 1.0 | 0.3% | 96.1% |
| 37 | MeVP12 (R) | ACh | 1 | 1.0 | 0.3% | 96.4% |
| 38 | MeVP17 (R) | Glu | 1 | 1.0 | 0.3% | 96.7% |
| 39 | MeVP21 (R) | ACh | 1 | 1.0 | 0.3% | 97.0% |
| 40 | MeVP41 (R) | ACh | 1 | 1.0 | 0.3% | 97.3% |
| 41 | MeVP49 (R) | unclear | 1 | 1.0 | 0.3% | 97.6% |
| 42 | MeVP52 (R) | ACh | 1 | 1.0 | 0.3% | 97.9% |
| 43 | MeVP64 (R) | Glu | 1 | 1.0 | 0.3% | 98.2% |
| 44 | MeVPaMe1 (R) | ACh | 1 | 1.0 | 0.3% | 98.5% |
| 45 | MeVPMe2 (R) | Glu | 1 | 1.0 | 0.3% | 98.8% |
| 46 | MeVPMe5 (L) | Glu | 1 | 1.0 | 0.3% | 99.1% |
| 47 | MeVPOL1 (R) | ACh | 1 | 1.0 | 0.3% | 99.4% |
| 48 | Tm29 (R) | Glu | 1 | 1.0 | 0.3% | 99.7% |
| 49 | TmY21 (R) | ACh | 1 | 1.0 | 0.3% | 100.0% |